Skip to content
10-Q

Quarterly Report

CHINA GEWANG BIOTECHNOLOGY, INC.

0001511164-16-001076

← back to feed
Filed
Oct 14, 2016 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2016 · Aug 31, 2016 75M sh
Stockholders Equity Q3 2016 · Aug 31, 2016 $26M
Stockholders Equity Q3 2016 · Nov 30, 2015 $8.96M
Current Liabilities Q3 2016 · Aug 31, 2016 $5.9M
Current Liabilities Q3 2016 · Nov 30, 2015 $405.35K
Current Assets Q3 2016 · Aug 31, 2016 $28.18M
Current Assets Q3 2016 · Nov 30, 2015 $9.3M
Total Assets Q3 2016 · Aug 31, 2016 $31.91M
Total Assets Q3 2016 · Nov 30, 2015 $9.36M
Sga Expense Q3 2016 · Aug 31, 2016 $235.27K
Sga Expense Q3 2016 · Aug 31, 2016 $495.21K
Sga Expense restated Q3 2016 · Aug 31, 2015 $120.38K
Sga Expense Q3 2016 · Aug 31, 2015 $308.64K
Operating Income Q3 2016 · Aug 31, 2016 $4.89M
Operating Income Q3 2016 · Aug 31, 2016 $6.99M
Operating Income Q3 2016 · Aug 31, 2015 $383.27K
Operating Income Q3 2016 · Aug 31, 2015 $1.33M
Gross Profit Q3 2016 · Aug 31, 2016 $7.44M
Gross Profit Q3 2016 · Aug 31, 2016 $10.73M
Gross Profit Q3 2016 · Aug 31, 2015 $715.89K
Gross Profit Q3 2016 · Aug 31, 2015 $2.18M
Cost Of Revenue Q3 2016 · Aug 31, 2016 −$11.15M
Cost Of Revenue Q3 2016 · Aug 31, 2016 −$14.52M
Cost Of Revenue Q3 2016 · Aug 31, 2015 −$350.49K
Cost Of Revenue Q3 2016 · Aug 31, 2015 −$897.55K
Revenue Q3 2016 · Aug 31, 2016 $18.59M
Revenue Q3 2016 · Aug 31, 2016 $25.24M
Revenue Q3 2016 · Aug 31, 2015 $1.07M
Revenue Q3 2016 · Aug 31, 2015 $3.07M
Operating Cash Flow Q3 2016 · May 31, 2016 −$6.99M
Operating Cash Flow Q3 2016 · May 31, 2015 $540.24K
Cash And Equivalents Q3 2016 · May 31, 2016 $9.79M
Cash And Equivalents Q3 2016 · Nov 30, 2015 $8.67M
Cash And Equivalents Q3 2016 · May 31, 2015 $8.26M
Cash And Equivalents Q3 2016 · Nov 30, 2014 $3.01M
Net Income Q3 2016 · May 31, 2016 $7.38M
Net Income Q3 2016 · May 31, 2015 $995.96K